Table 2 Surgical outcomes

From: Cytoreductive surgery and hyperthermic intrathoracic chemotherapy in thymic epithelial tumors with pleural spread or recurrence: a prospective, single-arm, phase II study

Variables

Total (N = 45)

Surgery, No. (%)

 P/D

3 (6.7)

 eP/D

42 (93.3)

Resection, No. (%)

 R0

23 (51.1)

 R1

8 (17.8)

 R2

14 (31.1)

Tumor in different zones, No. (%)

 I

41 (91.1)

 II

34 (75.6)

 III

23 (51.1)

 IV

32 (71.1)

 V

19 (42.2)

PTI, median score [IQR]

6 [5,9]

Combined resection, No. (%)

 Diaphragm

37 (82.2)

 Lung

35 (77.8)

 Pericardium

7 (15.6)

 Azygos vein

1 (2.2)

  1. P/D pleurectomy/decortication, eP/D extended pleurectomy/decortication, R0 complete cytoreductive surgery without residual visible disease, R1 optimal cytoreductive surgery with residual tumors measuring no more than 10 mm, R2 incomplete cytoreductive surgery with residual lesions measuring >10 mm in diameter, PTI pleural tumor index, LOS length of postoperative stay, IQR interquartile range.
Back to article page